Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries.
Récher C, Röllig C, Bérard E, Bertoli S, Dumas PY, Tavitian S, Kramer M, Serve H, Bornhäuser M, Platzbecker U, Müller-Tidow C, Baldus CD, Martínez-Cuadrón D, Serrano J, Martínez-Sánchez P, Arbolí ER, Gil C, Bergua J, Bernal T, de la Fuente Burguera A, Delabesse E, Bidet A, Pigneux A, Montesinos P.
Récher C, et al. Among authors: berard e.
Leukemia. 2022 Apr;36(4):913-922. doi: 10.1038/s41375-021-01425-9. Epub 2021 Nov 13.
Leukemia. 2022.
PMID: 34775483
Free PMC article.